Skip to content

Effect of Brihat panchamoola ghana vati and fomentation therapy with eranda patra in Gridhrasi or sciatica

A clinical evaluation of Brihat panchmoola ghana vati and Eranda patra pottali sweda in the management of Gridhrasi with special reference to Sciatica - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067889
Enrollment
90
Registered
2024-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Sponsors

Dr Rohit Kumar Mishra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group 20 to 60 years (irrespective of sex, race, caste, religion) 2.On the basis of sign and symptoms mentioned for Gridhrasi (either vataj or vata kaphaj) 3.SLR i.e. straight leg raising test, Bragard’s test (Lasegue test) positive 4.Patient willing for enroll in trial study. 5.Patient who are not taking any other medication for Gridhrasi.

Exclusion criteria

Exclusion criteria: 1.Age below 20 and above 60 years. 2.Patients having complications like uncontrolled diabetes mellitus, hypertension, tuberculosis of spine, fracture related to spine or malignancy of spine. 3.Known case of Cardiac diseases (ischemic heart disease, trauma, coronary artery disease, myocardial infarction etc.) 4.Pregnancy, Lactating Mother. 5.Any other chronic illnesss like T.B. etc.

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms like Ruka (Pain) Toda (Pricking sensation) Stambh (Stiffness) Spandan (Twitching) Aruchi (Anorexia) Tandra (Drowsiness) Gaurava (Heaviness) Timepoint: Evalutaion will be done in 15th, 30th, and 45th days.

Secondary

MeasureTime frame
Improvement on symptomatic relife in sciatica symptomaTimepoint: Evaluation on assesment basis will be done after 15 30 & 45 days

Countries

India

Contacts

Public ContactDr Meera Antiwal

BHU

antiwalmeera@gmail.com9451586325

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026